Getting crystal structure predictions right can save pharmaceutical companies hundreds of millions of dollars. Yet while the pharmaceutical industry might have a keen interest in predicting what crystal structures can form, and how stable they are, computational costs have priced out calculating the relevant properties for each compound from first principles. Now, Marcus Neumann, founder […]
Read More